Advertisement

Challenges and Optimization of Apheresis Procedures in Resource-Limiting Environments

  • Mickey B. C. KohEmail author
  • Senarath Banda Abeykoon Jayasekara
  • Rajeeka Lakmali Morawakage
Chapter
Part of the Advances and Controversies in Hematopoietic Transplantation and Cell Therapy book series (ACHTCT)

Abstract

Apheresis capabilties are increasingly part of the essential infrastructure of national health systems in resource limited countries. It is needed for the maintenance of a safe and sufficient blood supply and is a integral component of the hematopoietic progenitor cell transplant programs. Although there are initial capital costs for starting such a program, there has been confirmation of its cost-effectiveness and importance. Guidelines for stem cell collection and therapeutic apheresis as well as systematic training and qualification of the laboratory have been consistently identified as important areas to focus upon in resource limited countries. Also, highlighted in this chapter are country-specific examples with an overview of the unique challenges and opportunities that exist in setting up a viable apheresis service as well as an in-depth focus on the developmental pathways for achieving this.

Keywords

Apheresis Hematopoietic cell collection Transplant Resource limited countries 

References

  1. Agarwal P, Verma A (2009) Automated platelet collection using the latest aphaeresis devices in an Indian setting. Transfus Apheres Sci 41:135–138CrossRefGoogle Scholar
  2. Arogundade FA, Sanusi AA, Oguntola SO, Omotoso BA, Abdel-Rahman EM, Akinsola A, Balogun RA (2014) Benefits and challenges of starting a new therapeutic apheresis service in a resource-constrained setting. J Clin Apher 29(4):194–198.  https://doi.org/10.1002/jca.21328CrossRefPubMedGoogle Scholar
  3. Celluzzi CM, Keever-Taylor C, Aljurf M, Koh MB, Rabe F, Rebulla P, Sacchi N, Sanders J, McGrath E, Loper K, Alliance for Harmonisation of Cellular Therapy Accreditation (AHCTA) (2014) Training practices of hematopoietic progenitor cell-apheresis and -cord blood collection staff: analysis of a survey by the Alliance for harmonisation of cellular therapy accreditation. Transfusion 54(12):3138–3144.  https://doi.org/10.1111/trf.12753CrossRefPubMedGoogle Scholar
  4. Chaudhary R, Das SS, Agarwal P, Shukla JS (2005) Quality systems in automated plateletpheresis in hospital based blood transfusion service in North India. J Clin Apher 20:81–85CrossRefGoogle Scholar
  5. Eichbaum Q, Smid MW, Crookes R, Naim M, Mendrone A Jr, Marques JFC Jr, Marques MB (2014) Apheresis in developing countries around the world. J Clin Apher 30(4):238–246CrossRefGoogle Scholar
  6. Gyi AA, Mra R, Nyein HL, Aung T, Win N, Khin PT, Issaragrisil S, Srivastava A, Ma D, Koh M (2017) Where there’s a will, there’s a way: establishing hematopoietic stem cell transplantation in Myanmar. Poster presented at 59th annual meeting & exposition of American Society of Hematology Atlanta GA, December 9–12, 2017Google Scholar
  7. Howell C, Douglas K, Cho G, El-Ghariani K, Taylor P, Potok D, Rintala T, Watkins S (2015) Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. Transfus Med 25(2):57–78.  https://doi.org/10.1111/tme.12205CrossRefPubMedGoogle Scholar
  8. Koh MBC (2017) Considerations in setting up and planning a graft processing facility. Hematol Oncol Stem Cell Ther 10(4):195–197CrossRefGoogle Scholar
  9. Koh MBC, Lowdell M, Leemhuis T (2018) Essential requirements for setting up a stem cell processing laboratory. In: Gluckman É, Niederwieser D, Aljurf M (eds) Establishing a hematopoietic stem cell transplantation unit. Springer, Cham, pp 155–169CrossRefGoogle Scholar
  10. Leemhuis T, Padley D, Keever-Taylor C, Niederwieser D, Teshima T, Lanza F, Chabannon C, Szabolcs P, Bazarbachi A, Koh MBC on behalf of the Graft Processing Subcommittee of the Worldwide Network for Blood and Bone Marrow Transplantation (WBMT) (2014) Essential requirements for setting up a stem cell processing laboratory. Bone Marrow Transplant 49:1098–1105CrossRefGoogle Scholar
  11. McCullough TK, McCullough J (2013) Strengthening blood programs in developing countries. Transfus Apher Sci 49(3):408–415CrossRefGoogle Scholar
  12. Neyrinck M, Vrielink H, Joint Task Force for Apheresis Education and Certification (2015) Apheresis training for nurses and physicians around the World. J Clin Apher 30(1):32–37.  https://doi.org/10.1002/jca.21345CrossRefPubMedGoogle Scholar
  13. Schwartz J, Padmanabhan A, Aqui N, Balagun RA, Conelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH (2016) Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the writing committee of the American Society for Apheresis: the seventh special issue. J Clin Apher 31(3):149–162PubMedPubMedCentralGoogle Scholar
  14. Sharma RR, Saluja K, Jain A, Dhawan HK, Thakral B, Marwaha N (2011) Scope and application of therapeutic apheresis: experience from a tertiary care hospital in North India. Transfus Apher Sci 45:239–245CrossRefGoogle Scholar
  15. Srivastava R (2002) Changing perspectives of apheresis in India in the twentieth century. Transfus Apher Sci 26:97–101CrossRefGoogle Scholar
  16. Srivastava R (2006) Indian Society for Apheresis and apheresis tourism in India – is there a future? Transfus Apher Sci 34:139–144CrossRefGoogle Scholar
  17. Srivastava R, Gupta RC, Khatri PC, Lalchandani A (1998) Changing scenario of therapeutic apheresis in India in last 14 years. Ther Apheres 2(4):317–319CrossRefGoogle Scholar
  18. Tiwari AK, Dara RC, Pandey P, Arora D, Rawat G, Raina V (2016) Change in therapeutic apheresis practices: role of continuing medical education (CME). J Clin Apher 31(1):16–21.  https://doi.org/10.1002/jca.21397CrossRefPubMedGoogle Scholar
  19. Triyono T, Vrielink H (2015) Therapeutic apheresis in Asia: an Indonesia single center experience. J Clin Apher 30(3):139–140.  https://doi.org/10.1002/jca.21350CrossRefPubMedGoogle Scholar
  20. WHO (2011) Expert Committee on specifications for pharmaceutical preparations. (WHO technical report series (2011) no. 961)Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Mickey B. C. Koh
    • 1
    • 2
    Email author
  • Senarath Banda Abeykoon Jayasekara
    • 3
  • Rajeeka Lakmali Morawakage
    • 4
  1. 1.Department of HaematologySt George’s University Hospital HospitalsLondonUK
  2. 2.Blood Services GroupHealth Sciences AuthoritySingaporeSingapore
  3. 3.National Blood CentreNational Blood Transfusion Service of Sri LankaColomboSri Lanka
  4. 4.Regional Blood CentreNational Cancer Institute of Sri LankaMaharagamaSri Lanka

Personalised recommendations